Summary
Activated charcoal haemoperfusion offers potential clinical benefit for the treatment of end-stage chronic uraemia. Haemoperfusion has been shown to have plasma creatinine and plasma urate clearances superior to those obtained with conventional haemodialysis at comparable blood flow rates through the respective devices. Urea and phosphate removal, however, is inferior to conventional dialysis while water and electrolyte removal is negligible. Haemoperfusion therefore requires combination with dialysis or ultrafiltration apparatus in patients without high urine volumes in order to remove sufficient water and electrolytes. Molecules of 350 – 1500 daltons are removed more efficiently than by dialysis, and offer potential benefit to patients with specific complications of dialysis therapy such as peripheral neuropathy and pericarditis.
Haemostatic changes occurring with haemoperfusion are minor and present little clinical hazard to patients, although it would be desirable to reduce platelet loss to a minimum before repeated use of these devices is recommended.
Total solute removal of creatinine and urate, in a 2 h combined dialysis — ultrafiltration — haemoperfusion system is less than a longer period of conventional dialysis, but would appear to be sufficient for stable management of uraemic patients.
Preview
Unable to display preview. Download preview PDF.
References
Andrade, J. D., Kunitomo, K., Van Wagenen, R., Kastigir, B., Gough, D. and Kolff, W. J. (1971). Coated adsorbents for direct blood perfusion HEMA/ activated carbon. Trans. Amer. Soc. Artif Int. Organs, 17, 222–228.
Babb, A. L., Popovich, R. P., Christopher, T. G. and Scribner, B. H. (1971). The genesis of the square metre-hour hypothesis. Trans. Amer. Soc. Artif Im. Organs, 17, 81–91.
Babb, A. L., Farrell, P. C., Uvelli, D. A. and Scribner, B. H. (1972). Haemodialyser evaluation by examination of solute molecular spectra. Trans. Amer. Soc.Artif Int. Organs, 18, 98.
Babb, A. L., Strand, M. J., Uvelli, D. A., Milutinovic, J. and Scribner B. H. (1975). Quantitative description of dialysis treatment: a dialysis index. Kidney International, 7, S23–29.
Bergstrom, J. and Furst, P. (1976). Uraemic middle molecules. Clin. Nephrol. 5, 143–152.
Bright, R. (1836). Cases and observations illustrative of renal disease accompanied by the secretion of albuminous urine. Guy’s Hospital Report, 1, 338–379.
Brunner, F. P., Giesecke, B., Gurland, H. J., Jacobs, C., Parsons, F. M., Scharer, K., Seyffart, G., Spies, G. and Wing, A. J. (1975). Combined report on intermittent dialysis and transplantation in Europe. Proc. Eur. Dial. Transpl. Assoc., 12, 3–64.
Bryan, F. A. (1974). Sixth Annual Progress Report 1973–1974: The National Dialysis Registry. National Institutes of Arthritis, Metabolism and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014.
Chang, T. M. S. (1966). Semipermeable aquaeous microcapsules (‘artificial cells’): with emphasis on experiments in an extracorporeal shunt system. Trans. Amer. Soc. Artif Int. Organs, 12, 13.
Chang, T. M. S. (1969). Removal of endogenous and exogenous toxins by a microencapsulated adsorbent. Can. J. Physiol. Pharmacol., 47, 1043–1045.
Chang, T. M. S. (1974). A comparison of semipermeable microcapsules and standard dialysers for use in separation. Separation and Purification Methods, 3, (2), 245–262.
Chang, T. M. S., Pont, A., Johnson, L. J. and Malave, N. (1968). Response to intermittent extracorporeal perfusion through shunts containing semipermeable microcapsules. Trans. Amer. Soc. Artif. Int. Organs, 14, 162–168.
Chang, T. M. S., and Malave, N. (1970). The development and first clinical use of semipermeable microcapsules (artificial cells) as a compact artificial kidney. Trans. Amer. Soc. Artif Int. Organs, 16, 141–148.
Chang, T. M. S., Gonda, A., Dirks, J. H. and Malave, N. (1971). Clinical evaluation of chronic intermittent and short-term haemoperfusion in patients with chronic renal failure using semipermeable microcapsules (artificial cells) formed from membrane coated activated charcoal. Trans. Amer. Soc. Artif Int. Organs, 17, 246–252.
Chang. T. M. S., Gonda, A., Dirks, J. H., Coffey, J. F. and Burns, T. (1972). ACAC microcapsule artificial kidney for the long-term and short-term manage-ment of patients with chronic renal failure. Trans. Amer. Soc. Artif Int. Organs, 18, 465–472.
Chang, T. M. S. and Migchelsen, M. (1973). Characterisation of possible ‘toxic’ metabolites in uraemia and hepatic coma based on the clearance spectrum for larger molecules by the ACAC microcapsule artificial kidney. Trans. A ner. Soc. Artif Int. Organs, 19, 314–319.
Chang, T. M. S., Migchelsen, M., Coffey, J. F. and Stark, A. (1974). Serum middle molecule levels in uraemia during long-term intermittent haemoperfusions with the ACAC (coated charcoal) microcapsule artificial kidney. Trans. Amer. Soc. Artif Int. Organs, 20, 364–371.
Chang, T. M. S., Chirito, E., Barre, B., Cole, C. and Hewish, M. (1975). Clinical performance-characteristics of a new combined system for simultaneous haemoperfusion-haemodialysis-ultrafiltration in series. Trans. Amer. Soc. Artif. Int. Organs, 21, 502–508.
Chang, T. M. S., Chirito, E., Barre, P. and Resureccion, E. (1976). The use of ACAC microencapsulated charcoal haemoperfusion in series with Amicon ultrafiltration for patients with chronic renal failure. Abstracts, Amer. Soc. Artif Int. Organs, 5, 15.
Dunea, G. and Koiff, W. J. (1965). Clinical experience with the Yatzidis charcoal artificial kidney. Trans. Amer. Soc. Artif Int. Organs, 11, 178–182.
Dunea, G., Rizvi, S. H., Mamdani, B. H., Anicama, H. J. and Mahurkar, S. D. (1976). Charcoal hemoperfusion and combination dialysis-haemoperfusion in chronic renal failure. Abstracts Amer. Soc. Artif Int. Organs, 5, 22.
Flendrig, J. A., Kruis, H. and Das, H. A. (1976). Aluminium intoxication: the cause of dialysis dementia? Proc. Eur. Dial. Transpl. Assoc., 13, 355.
Friedman, E. A. (1976). Oxidised starch and oral charcoal in uraemic patients. Kidney International (in press).
Friedman, E. A., Laungani, G. B. and Beyer, M. M. (1975). Life prolongation in nephrectomized rats fed oxidized starch and charcoal. Kidney International, 7, 377–379.
Funck-Brentano, J. L., Man, N. K., Sausse, A., Cueille, G., Zingraff, J., Drueke, T., Jungers, P. and Billon, J. P. (1975). Neuropathy and ‘middle’ molecule toxin. Kidney International, 7, 352–356.
Funck-Brentano, J. L., Man, N. K., Sausse, A., Zingraff, J., Cloix, J. F., Becker, A. and Cueille, G. (1976). Characterisation of a 1100–1300 MW uraemic neurotoxin. Trans. Amer. Soc. Artif. Int. Organs, 22, 163.
Gazzard, B. G., Portmann, B. A., Weston, M. J., Langley, P. G., Murray-Lyon, I. M., Dunlop, E. H., Flax, H., Mellon, P. J., Record, C. O., Ward, M. B. and Williams, R. (1974). Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet, 1, 1301–1307.
Gordon, A., Gral, T., De Palma, J. R., Greenbaum, M. A., Marantz, L. B., MacArthur, M. J. and Maxwell, M. H. (1970). A sorbent-based low-volume dialysate system. Preliminary studies in human subjects. Proc. Eur. Dial. Transpl. Assoc. 7, 63–68.
Gordon, A., Furst, P., Bergstrom, J., Lewin, A., Rosenfeld, M. D. J., Roberts, M. and Maxwell, M. H. (1976). Adsorption of uremic toxins. Proc. 6th Int. Cong. Nephroi. (in press).
Graham, T. (1854). Bakerian lecture on osmotic force. Phil. Trans. Roy. Soc., London, p. 177.
Hagstam, K. E., Larsson, L. E. and Thysell, H. (1966). Experimental studies on charcoal haemoperfusion in phenobarbital intoxication and uraemia, including histopathologic findings. Acta. Med. Scand., 180, 593–603.
Johnson, W. J., Hagge, W. W., Wagoner, R. D., Dinapoli, R. P. and Rosevear,J. W. (1975). Toxicity arising from urea. Kidney International, 7, S288–293.
Jones, J. D. and Burnett, P. C. (1975). Creatinine metabolism and toxicity. Kidney International, 7 S294–298.
Kolff, W. J., and Berk, H. T. J. (1944). Artificial kidney: dialyser with great area. Acta Med. Scand., 117, 121–134.
Leber, H. W., Neuhauser, M., Goubeaud, G. and Schutterle, W. (1976). Removal of toxic middle molecular solutes from uraemic serum by haemoperfusion. Abstracts, Eur. Dial. Transp. Assoc., p. 265.
Malchesky, P. S., Nokoff, R., Varnes, W. and Nosé, Y. (1976) The charcoal capillary hemoperfusion system. Proc. 13th Eur. Dial. Transpl. Assoc., 13, 242.
Muirhead, E. E. and Reid, A. F. (1948). A resin artificial kidney. J. Lab. Clin. Med., 33, 841–844.
Ota, K., Ohta, T., Kobayashi, M., Yoshida, S., Kaneko, 1., Agishi, T. Sugihara, M. (1976). Petroleum based activated charcoal for direct haemoperfusion. Proc. Eur. Dial. Transp. Assoc., 13, 250.
Sparks, R. E. (1975). Gastrosorbents in the therapy of uraemia; inferences from intestinal loop dialysis. Kidney International, 7, S373–376.
Stephen, R. L., Jacobsen, S. C., Atkin-Thor, E. and Kilff, W. J. (1975). Portable/ wearable artificial kidney (WAK) -initial evaluation. Proc. Eur. Dial. Transpl. Assoc., 12, 26.
Ward, M. K., Pierides, A. M., Fawcett, P., Shaw, D. A., Perry, R. H., Tomlinson, B. E. and Kerr, D. N. S. (1976). Dialysis encephalopathy syndrome. Proc. Europ. Dial. Transpl. Assoc., 13, 348.
Winchester, J. F. (1976). Working luncheon on adsorbent haemoperfusion for uraemia, acute intoxication and liver failure. 22nd Amer. Soc. Artif. Int. Organs, San Francisco.
Winchester, J. F., Tilstone, W. J., Edwards, R. O., Gilchrist, T. and Kennedy, A. C. (1974). Haemoperfusion for enhanced drug elimination - a kinetic analysis in paracetamol poisoning. Trans. Amer. Soc. Artif. Int. Organs, 20, 358–363.
Winchester J. F., Edwards, R. O., Tilstone, W. J. and Woodcock, B. G. (1975a). Activated charcoal haemoperfusion and experimental acetaminophen poisoning. Toxicol. Appl. Pharmacol. 31, 120–127.
Winchester, J. F.,Apiliga, M. T., Mackay, J. M. and Kennedy, A. C. (1975b). Haemodialysis with charcoal haemoperfusion. Proc. Eur. Dial. Transpl. Assoc., 12, 526–533.
Winchester, J. F. Apiliga, M. T. and Kennedy, A. C. (1976). Short term evaluation of charcoal haemoperfusion combined with dialysis in uraemic patients. Kidney International (in press).
Yatzidis, H. (1964). A convenient haemoperfusion micro-apparatus over charcoal for the treatment of endogenous and exogenous intoxications. Its use as an artificial kidney. Proc. Eur. Dial. Transpl. Assoc., 1, 83–87.
Editor information
Editors and Affiliations
Copyright information
© 1977 Bioengineering Unit, University of Strathclyde
About this chapter
Cite this chapter
Winchester, J.F. (1977). Clinical Application of Haemoperfusion in Uraemia. In: Kenedi, R.M., Courtney, J.M., Gaylor, J.D.S., Gilchrist, T., Gerard, S.M. (eds) Artificial Organs. Strathclyde Bioengineering Seminars. Palgrave, London. https://doi.org/10.1007/978-1-349-03458-1_23
Download citation
DOI: https://doi.org/10.1007/978-1-349-03458-1_23
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-03460-4
Online ISBN: 978-1-349-03458-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)